Gator Bio

Gator Bio is a private, revenue-generating company commercializing an advanced Biolayer Interferometry (BLI) platform for real-time, label-free analysis of molecular interactions. Its technology is positioned as a faster, more intuitive, and high-throughput alternative to legacy systems like Biacore and Octet, serving critical workflows in biopharma R&D, particularly antibody discovery and characterization. The company operates a platform business model, generating revenue from instrument sales, consumable biosensors, and software, while also offering custom probe development services. With strong customer testimonials highlighting its ease of use and reliability, Gator Bio is carving out a significant niche in the biomolecular interaction analysis market.

Next-Generation Biolayer Interferometry (BLI) for label-free, real-time analysis of biomolecular interactions (kinetics, affinity, concentration). Platform includes instruments, biosensors, and software.

The primary competitors are Cytiva (with its Biacore SPR platform) and Sartorius (with its Octet BLI platform), both of which are well-entrenched in the market. Gator Bio differentiates itself by emphasizing superior ease of use, lower cost of ownership, high reliability, and exceptional customer support. It also competes with other label-free and label-based interaction analysis technologies, but its focused BLI innovation aims to offer the best blend of throughput, data quality, and workflow simplicity.